Comparison CASI Pharmaceuticals (CASI) with Competitors
CASI Pharmaceuticals (CASI) industry is Biotechnology.
Debt-to-Equity
CASI-51.47%
Industry29.76%
Upside-81.23%
P/E
CASI-0.09
Industry-18.88
Upside+1878.96%
CASI Pharmaceuticals (CASI) industry is Biotechnology.